To: agiak who wrote (1020 ) 7/20/1998 12:19:00 AM From: WTT2 Read Replies (1) | Respond to of 2038
DYGN will be a big mover this week. On TV twice this weekend.. Saw the interview w/ Cusick.. It went extremely well. There is alot of buzz all over the internet. Read the news below: Generic Drug Market Picks Up Where Patents Left Off HOLLYWOOD, Calif.--(BUSINESS WIRE)--July 17, 1998--Emerging Company Report, the nationally syndicated television program that profiles emerging-growth companies (http://www.emergingcompany.com), features an interview this week with the people behind DynaGen Inc. (Nasdaq:DYGN). Chairman Bob Cusick and director of Corporate Communications Cathy Bardwick discussed DynaGen's business strategy toward the generic pharmaceuticals business. "Lately, pharmaceutical companies like Glaxo Wellcome (NYSE:GLX) have been very hot on Wall Street as new, patented drugs are introduced," said Cusick. "Once those patents expire, it opens the door for generic versions of those drugs to be manufactured and sold. Industry estimates are that the generic drug market will expand from the current $8 billion to $15-16 billion per year." Over the next four years, there are a number of branded drugs that enjoy large market share, whose patents are due to expire. DynaGen feels it is positioned, through its business strategy, to grow its company from $25 million to $100 million per year over the next several years. information to interested individuals, which viewers can receive in the mail by calling a toll-free number on the TV screen. Emerging Company Report is seen Friday evenings at 11 p.m. ET, 8 p.m. PT, and again in Sunday morning at 11:30 a.m. ET, 8:30 a.m. PT on 140 cable TV systems nationwide. The program can also be viewed "On-Demand" atemergingcompany.com . Visitors to the Web site can also request free information, via e-mail, about featured companies. CONTACT: Emerging Company Report 805/336-0507emergingcompany.com